Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-003191
Filing Date
2022-01-11
Accepted
2022-01-11 16:30:58
Documents
2
Group Members
ELI GABSOENRIGHT HOLDING CORP.MERCURY ADVISORY LTDTRUMANO INTERNATIONAL INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm222609d1_sc13ga.htm SC 13G/A 97447
2 EXHIBIT 99.1 tm222609d1_ex99-1.htm EX-99.1 10414
  Complete submission text file 0001104659-22-003191.txt   109713
Mailing Address 660 MADISON AVENUE 18TH FLOOR NEW YORK NY 10021
Business Address 660 MADISON AVENUE 18TH FLOOR NEW YORK NY 10021 2126519000
MAINFIELD ENTERPRISES INC (Filed by) CIK: 0001226883 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY
Type: SC 13G/A

Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Subject) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88005 | Film No.: 22524247
SIC: 2835 In Vitro & In Vivo Diagnostic Substances